Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 1997

View Archived Issues

New antitumor agent from Teikoku Hormone characterized in mice

Promising data with Parkinson's disease diagnostic reported

COX-2 inhibitors from Merck Frosst

Janssen and Neurocrine Biosciences disclose CRF antagonists

Astra discloses iNOS inhibitors

Tachykinin antagonists prepared by Merck & Co.

Cerebroprotective activity of novel free radical scavenger established in animal model

Preclinical neuroprotective activity of P&U antioxidants

Merck & Co. fibrinogen antagonist characterized in animals

New pharmacological data reported for Novo Nordisk/Lilly muscarinic agent

Nymox Pharmaceuticals outlines R&D pipeline

Nycomed: Q1 1997 highlights

Salix Holdings: Q1 1997 highlights

Fujisawa: FY 1997 highlights

DHEA enters phase II/III trials

Aciclovir demonstrates antiasthmatic activity in animal model

Multinational trial assesses efficacy and safety of tolterodine for incontinence

Generic aciclovir approved by FDA

DepoTech reacquires certain marketing rights to DepoCyt

IVIg for acute cardiomyopathy

Development of anti-cytokine antibody product for RA progresses

Millennium BioTherapeutics discovers novel chemokine implicated in brain inflammation

Xytronyx's Periodontal Tissue Monitor nears U.S. approval

Preclinical validation of Techniclone's Vasopermeation Enhancement technology

Inflazyme granted Australian patent for antiinflammatory agents

Palatin's LeuTech demonstrates rapid and accurate imaging of sites of infection

TKT reaches milestone in second Gene Activation collaboration with HMR

Copernicus Gene Systems and Inex establish gene delivery collaboration

Transdermal buspirone patch shows encouraging results in ADHD

Promising clinical results reported for Flt3 ligand as stem cell mobilizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...